TheScreener - Dis-Chem Pharmacies (19T8) DIS-CHEM PHARMA sees an upgrade to Positive due to a better fundamental star rating

Report

TheScreener

EUR 14.00 For Business Accounts Only

DIS-CHEM PHARMA sees an upgrade to Positive due to a better fundamental star rating

The general evaluation of DIS-CHEM PHARMA (ZA), a company active in the Drug Retailers industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as defensive. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Positive. As of the analysis date March 22, 2022, the closing price was ZAR 36.99 and its potential was estimated at ZAR 39.62.

23/03/2022 1 EN

Underlying

Dis-Chem Pharmacies

Dis-Chem Pharmacies Limited, formerly Dis-Chem Pharmacies Proprietary Limited, is a pharmacy company in South Africa. In addition to pharmaceutical products and services, its retail pharmacies also sell personal care and beauty, healthcare and nutrition and baby care products, as well as confectionary, dry grocery, household and other ancillary products. It offers dispensary products, including diagnostics, first aid, and mobility and incontinence; beauty products, including beauty accessories, color cosmetics, face care, fragrance and skin care; toiletries products, including bath care, body care, foot care, hair care, oral care and shaving; electrical products, including heating and cooling, household and lifestyle, and household products, including cleaners and fresheners, insecticides, kitchen tools, purifiers and veterinary. It also offers vitamin products, sports supplements, and sports equipment and aids, and foods and specialized diet. It has over 101 stores in South Africa.

See profile

ZAE000227831 Johannesburg Stock Exchange South Africa

Provider

TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.

See profile

Other Reports on these Companies

Avior Capital Markets

Dis-Chem Pharmacies | Inflection point

Direct and indirect costs from two consecutive strikes over the last two years will leave DCP's FY '20 earnings on FY '17 earnings despite the Group growing revenue by c.13% pa. Adjusting for the once-off impacts, we estimate the Group would have grown earnings in line with revenue. This is despite low inflation and the additional costs from aggressive store expansion constraining margins. In our view, the Group's earnings trajectory is normalising. DCP's store expansion is moderating and maturing trading densities will contribute to a four-year revenue CAGR of c.14%. According to our est...

November 14, 2019 November 14, 2019 12 EN

Avior Capital Markets

Dis-Chem Pharmacies | Adjusting for anomalies

Dis-Chem (DCP) were recently hosts to sell-side analysts on a site visit to its three stores in the Greenstone node in Gauteng, to explain its store co-location strategies. Management also gave detail on sizable once-off items and rebate timing issues from the last 12 months, which will unwind in FY '20 and optically skew the company's underlying earnings growth trajectory. DCP's store rollout strategy over the last two years identifies greenfield locations and regions with existing mature stores (co-location). The co-location roll-out strategy is also a pre-emptive offense against peers al...

September 11, 2019 September 11, 2019 14 EN

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

AC ENERGY CORP (PH), a company active in the Alternative Electricity industry, now shows a lower overall rating. The independent financial analyst theScreener confirms the fundamental rating of 4 out of 4 stars. However, the market behaviour deterioration triggered a risk requalification, which can be thus described as moderately risky. theScreener believes that increased risk justifies the general evaluation downgrade to Neutral. As of the analysis date April 8, 2022, the closing price was PHP 8.54 and its expected value was estimated at PHP 8.53.

Free Trial

April 9, 2022 April 9, 2022 1 EN

With a more favourable environment, VUKILE PROPERTY improves to Positive

VUKILE PROPERTY (ZA), a company active in the Real Estate Holding & Development industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 4 out of 4 stars, as well as its unchanged, defensive market behaviour. The title leverages a more favourable environment and raises its general evaluation to Positive. As of the analysis date April 5, 2022, the closing price was ZAR 13.72 and its potential was estimated at ZAR 15.16.

Free Trial

April 6, 2022 April 6, 2022 1 EN

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of ROYAL BAFOKENG PLATINUM (ZA), active in the Platinum & Precious Metals industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date April 5, 2022, the closing price was ZAR 159.78 and its target price was estimated at ZAR 127.50.

Free Trial

April 6, 2022 April 6, 2022 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

DIS-CHEM PHARMA sees an upgrade to Positive due to a better fundamental star rating

Empowering Investors

Dis-Chem Pharmacies | Inflection point

Dis-Chem Pharmacies | Adjusting for anomalies

AC ENERGY CORP increases its risk exposure and slightly lowers to Neutral

With a more favourable environment, VUKILE PROPERTY improves to Positive

An unfavourable environment weighs on ROYAL BAFOKENG PLATINUM, which sees a downgrade to Slightly Negative

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe